{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:36:14Z","timestamp":1774125374944,"version":"3.50.1"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The genetically detoxified<jats:italic>Bordetella pertussis<\/jats:italic>adenylate cyclase is a promising delivery system for immunodominant tuberculosis antigens in gamma interferon release assays. This system has not been evaluated in human immunodeficiency virus (HIV)-infected persons in high tuberculosis prevalence areas. A whole-blood gamma interferon release assay with<jats:italic>Mycobacterium tuberculosis<\/jats:italic>antigens (early-secreted antigenic target 6, culture filtrate protein 10, alpha-crystallin 2, and TB10.3) delivered by adenylate cyclase in addition to native tuberculosis antigens (without adenylate cyclase delivery) was evaluated in 119 adults in Khayelitsha Township, Cape Town, South Africa. Results were compared to tuberculin skin test results of 41 HIV-positive and 42 HIV-negative asymptomatic persons, in addition to 36 HIV-positive persons with recently diagnosed smear- or culture-positive pulmonary tuberculosis. Delivery of tuberculosis antigens by adenylate cyclase decreased by 10-fold the amount of antigen required to restimulate T cells. Furthermore, the responses of HIV-positive persons with a low response to native tuberculosis antigens were enhanced when these antigens were delivered by adenylate cyclase. When gamma interferon responses to the tuberculosis antigens (with or without delivery by adenylate cyclase) were combined, a significantly higher number of patients were scored positive than by tuberculin skin testing. Ex vivo responses to tuberculosis antigens delivered by adenylate cyclase are maintained in the context of HIV infection. Our findings suggest that the majority of those in this population are infected with tuberculosis, which is of significant public health importance.<\/jats:p>","DOI":"10.1128\/cvi.00041-07","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T01:10:18Z","timestamp":1179969018000},"page":"847-854","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["Enhanced Ex Vivo Stimulation of<i>Mycobacterium tuberculosis<\/i>-Specific T Cells in Human Immunodeficiency Virus-Infected Persons via Antigen Delivery by the<i>Bordetella pertussis<\/i>Adenylate Cyclase Vector"],"prefix":"10.1128","volume":"14","author":[{"given":"Tom G.","family":"Connell","sequence":"first","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muki S.","family":"Shey","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnett","family":"Seldon","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molebogeng X.","family":"Rangaka","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"van Cutsem","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Simsova","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Marcekova","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sebo","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Diwakar","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme A.","family":"Meintjes","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Leclerc","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin A.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa"},{"name":"Department of Paediatrics, University of Melbourne, Infectious Diseases Unit, Department of General Medicine, and Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Me\u0301decins Sans Frontie\u0300res, Khayelitsha site B, South Africa"},{"name":"Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic"},{"name":"Unite de Re\u0301gulation Immunitaires et Vaccinologie, Inserm E352, Institut Pasteur, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"141","volume":"21","year":"1999","unstructured":"Anastos, K., L. A. Kalish, H. Palacio, C. A. Benson, R. Delapenha, K. Chirgwin, L. Stonis, and E. E. Telzak. 1999. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS). J. Acquir. Immune Defic. Syndr.21:141-147.","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","volume":"356","year":"2000","unstructured":"Andersen, P., M. E. Munk, J. M. Pollack, and M. T. Doherty. 2000. Specific immune-based diagnosis of tuberculosis. The Lancet.356:1099-1104.","journal-title":"The Lancet."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.200509-1526OC","volume":"173","year":"2006","unstructured":"Anderson, S. T., A. J. Williams, J. R. Brown, S. M. Newton, M. Simsova, M. P. Nicol, P. Sebo, M. Levin, R. J. Wilkinson, and K. A. Wilkinson. 2006. Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing. Am. J. Respir. Crit. Care Med.173:1038-1042.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_5_2","first-page":"86","volume":"81","year":"2006","unstructured":"Anonymous. 2006. The global plan to stop TB, 2006-2015: summary. Wkly. Epidemiol. Rec.81:86-88.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1099\/00221287-144-11-3195","volume":"144","year":"1998","unstructured":"Berthet, F. X., P. B. Rasmussen, I. Rosenkrands, P. Andersen, and B. Gicquel. 1998. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology144(Pt. 11):3195-3203.","journal-title":"Microbiology"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-7-56","volume":"7","year":"2006","unstructured":"Brock, I., M. Ruhwald, B. Lundgren, H. Westh, L. R. Mathiesen, and P. Ravn. 2006. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir. Res.7:56.","journal-title":"Respir. Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200211220-00008","volume":"16","year":"2002","unstructured":"Chapman, A. L., M. Munkanta, K. A. Wilkinson, A. A. Pathan, K. Ewer, H. Ayles, W. H. Reece, A. Mwinga, P. Godfrey-Faussett, and A. Lalvani. 2002. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS16:2285-2293.","journal-title":"AIDS"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200404090-00006","volume":"18","year":"2004","unstructured":"Coetzee, D., K. Hildebrand, A. Boulle, G. Maartens, F. Louis, V. Labatala, H. Reuter, N. Ntwana, and E. Goemaere. 2004. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS18:887-895.","journal-title":"AIDS"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"A11","DOI":"10.1111\/j.1365-3156.2004.01259.x","volume":"9","year":"2004","unstructured":"Coetzee, D., K. Hilderbrand, E. Goemaere, F. Matthys, and M. Boelaert. 2004. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop. Med. Int. Health9:A11-A15.","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/14737159.6.5.663","volume":"6","year":"2006","unstructured":"Connell, T. G., M. X. Rangaka, N. Curtis, and R. J. Wilkinson. 2006. QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection? Expert Rev. Mol. Diagn.6:663-677.","journal-title":"Expert Rev. Mol. Diagn."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1086\/514016","volume":"176","year":"1997","unstructured":"Converse, P. J., S. L. Jones, J. Astemborski, D. Vlahov, and N. M. Graham. 1997. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J. Infect. Dis.176:144-150.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","year":"2003","unstructured":"Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med.163:1009-1021.","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1097\/01.aids.0000191923.08938.5b","volume":"19","year":"2005","unstructured":"Dheda, K., A. Lalvani, R. F. Miller, G. Scott, H. Booth, M. A. Johnson, A. Zumla, and G. A. Rook. 2005. Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. Aids19:2038-2041.","journal-title":"Aids"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.193.9.1035","volume":"193","year":"2001","unstructured":"Guermonprez, P., N. Khelef, E. Blouin, P. Rieu, P. Ricciardi-Castagnoli, N. Guiso, D. Ladant, and C. Leclerc. 2001. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the \u03b1M\u03b22 integrin (CD11b\/CD18). J. Exp. Med.193:1035-1044.","journal-title":"J. Exp. Med."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.4049\/jimmunol.162.4.1910","volume":"162","year":"1999","unstructured":"Guermonprez, P., D. Ladant, G. Karimova, A. Ullmann, and C. Leclerc. 1999. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J. Immunol.162:1910-1916.","journal-title":"J. Immunol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.vaccine.2004.11.030","volume":"23","year":"2005","unstructured":"Hogarth, P. J., K. E. Logan, H. M. Vordermeier, M. Singh, R. G. Hewinson, and M. A. Chambers. 2005. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c\u2014a member of the esat-6 gene family. Vaccine23:2557-2564.","journal-title":"Vaccine"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1164\/ajrccm.158.6.9803104","volume":"158","year":"1998","unstructured":"Johnson, J. L., S. Nyole, A. Okwera, C. C. Whalen, P. Nsubuga, V. Pekovic, R. Huebner, R. S. Wallis, P. N. Mugyenyi, R. D. Mugerwa, and J. J. Ellner. 1998. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Am. J. Respir. Crit. Care Med.158:1790-1796.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(04)17592-2","volume":"364","year":"2004","unstructured":"Liebeschuetz, S., S. Bamber, K. Ewer, J. Deeks, A. A. Pathan, and A. Lalvani. 2004. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet364:2196-2203.","journal-title":"Lancet"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.1002-1005.2002"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.178.5.1274-1282.1996"},{"key":"e_1_3_2_22_2","first-page":"49","volume":"54","year":"2005","unstructured":"Mazurek, G. H., J. Jereb, P. Lobue, M. F. Iademarco, B. Metchock, and A. Vernon. 2005. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. Morb. Mortal. Wkly. Rep. Recommend. Rep.54:49-55.","journal-title":"Morb. Mortal. Wkly. Rep. Recommend. Rep."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","volume":"175","year":"2007","unstructured":"Rangaka, M. X., K. A. Wilkinson, R. Seldon, G. van Cutsem, G. A. Meintjes, C. Morroni, P. Mouton, L. Diwakar, T. G. Connell, G. Maartens, and R. J. Wilkinson. 2007. Effect of HIV-1 Infection on T-cell-based and skin test detection of tuberculosis infection. Am. J. Respir. Crit. Care Med.175:514-520.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200509-1516PP","volume":"174","year":"2006","unstructured":"Richeldi, L. 2006. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med.174:736-742.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1073\/pnas.94.7.3314","volume":"94","year":"1997","unstructured":"Saron, M. F., C. Fayolle, P. Sebo, D. Ladant, A. Ullmann, and C. Leclerc. 1997. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. USA94:3314-3319.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.4049\/jimmunol.173.10.6089","volume":"173","year":"2004","unstructured":"Schlecht, G., J. Loucka, H. Najar, P. Sebo, and C. Leclerc. 2004. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming. J. Immunol.173:6089-6097.","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.10.5446-5453.2002"},{"key":"e_1_3_2_28_2","first-page":"939","volume":"10","year":"2006","unstructured":"Tsiouris, S. J., J. Austin, P. Toro, D. Coetzee, K. Weyer, Z. Stein, and W. M. El-Sadr. 2006. Results of a tuberculosis-specific IFN-\u03b3 assay in children at high risk for tuberculosis infection. Int. J. Tuberc. Lung Dis.10:939-941.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.11.6255-6261.2004"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.5.2991-2998.2005"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.4049\/jimmunol.174.7.4237","volume":"174","year":"2005","unstructured":"Wilkinson, K. A., G. R. Stewart, S. M. Newton, H. M. Vordermeier, J. R. Wain, H. N. Murphy, K. Horner, D. B. Young, and R. J. Wilkinson. 2005. Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2. J. Immunol.174:4237-4243.","journal-title":"J. Immunol."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00041-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00041-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T23:36:38Z","timestamp":1683848198000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00041-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1128\/CVI.00041-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00041-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"2006-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-05-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}